1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Ultrasound Systems Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Ultrasound Systems Market, United States
3.1 Ultrasound Systems Market, United States, Revenue ($m), 2018-2033
3.2 Ultrasound Systems Market, United States, Volume (Units), 2018-2033
3.3 Ultrasound Systems Market, United States, Average Price ($), 2018-2033
3.4 Ultrasound Systems Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Ultrasound Systems Market
4.1 GE HealthCare Technologies Inc
4.1.1 Company Overview
4.2 Siemens Healthineers AG
4.2.1 Company Overview
4.3 Philips Healthcare Informatics Inc
4.3.1 Company Overview
4.4 Canon Medical Systems Corp
4.4.1 Company Overview
4.5 Samsung Medison Co Ltd
4.5.1 Company Overview
4.6 Fujifilm Holdings Corp
4.6.1 Company Overview
4.7 Hitachi Healthcare Manufacturing Ltd
4.7.1 Company Overview
6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 GE HealthCare Technologies Raises USD1 Billion in Public Offering of 4.800% Senior Notes Due 2029
6.1.2 Exo Imaging Raises USD14.2 Million in Debt Financing
6.1.3 OPKO Health to Raise USD250 Million in Public Offering of 7.5% Notes Due 2044
6.2 Equity Offerings
6.2.1 QT Imaging to Raise USD1 Million in PIPE Investment
6.2.2 GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares
6.2.3 GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares
7 Recent Developments
7.1 Corporate Communications
7.1.1 Apr 09, 2025: SecondWave secures $7m in funding for ultrasound device
7.1.2 Feb 21, 2025: Noris Medical Receives FDA 510(k) Clearance for LONGY-N Implant
7.1.3 Sep 23, 2024: OPKO Health’s ModeX Therapeutics Names Giovanni Abbadessa as Chief Medical Officer
7.1.4 Jul 29, 2024: UT Tyler receives $481K grant for cutting-edge ultrasound research
7.2 Financial Announcements
7.2.1 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025
7.2.2 Jan 23, 2025: GE Aerospace Announces Fourth Quarter 2024 Results
7.2.3 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025
7.2.4 Nov 12, 2024: Oxford Instruments Announces Half-Year Results
7.3 Government and Public Interest
7.3.1 Mar 17, 2025: Enveric Biosciences Participating in BIO-Europe Spring
7.3.2 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference
7.3.3 Sep 27, 2024: An Ultrasound-Activated Hydrogel for Steady, Sustained Drug Delivery
7.3.4 Sep 25, 2024: Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study
7.3.5 Sep 25, 2024: Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension
7.3.6 Aug 23, 2024: Moderna Receives Approval for RSV Vaccine mRESVIA
7.3.7 Aug 22, 2024: Phase 3 Results of GERD Drug Jaqbo Published in Leading Gastroenterology Journal
7.4 Other Significant Developments
7.4.1 Jun 16, 2025: Debiopharm’s ADC Research Gains Momentum With Launch of First-in-human Trial Assessing Debio 1562M in Acute Myeloid Leukemia Patients
7.4.2 Mar 31, 2025: New Ultrasound Imaging Technique Helps Doctors See Inflammatory Bowel Disease Activity at the Bedside with no Sedation or Radiation
7.4.3 Jan 13, 2025: EDAP Announces Preliminary Record Fourth Quarter Focal One System Sales and Record U.S. Procedures
7.4.4 Nov 12, 2024: Cadrenal Therapeutics Highlights Presentation at European Association for Cardio-Thoracic Surgery Medical Congress
7.4.5 Nov 05, 2024: Mindray Partners with TeleRay to Streamline Ultrasound Delivery and Enhance Outcomes
7.4.6 Oct 14, 2024: Norton Healthcare Acquires Groundbreaking Focused Ultrasound Technology
7.4.7 Sep 11, 2024: Global Ultrasound Institute Unveils Groundbreaking Liver Essentials Course and Fellowship Program
7.4.8 Jul 31, 2024: Rett Syndrome Patients Show Further Clinical Improvement After 20 Weeks of NTI164 Treatment
7.5 Product News
7.5.1 Jun 16, 2025: GE HealthCare Expands the bkPortfolio With Introduction of bkActiv S Series for Guiding Nonsurgical Urology, Colorectal and Pelvic Floor Procedures
7.5.2 Jun 11, 2025: Researchers Solve Ultrasound Imaging Problem Using Seismology Technique
7.5.3 May 14, 2025: “Clinically Compelling” Study Shows Contrast-Enhanced Ultrasound (CEUS) Is Safe and Saves Lives
7.5.4 Mar 31, 2025: Non-Invasive Ultrasound Treatment Shows Promise for Neuropathic Pain Relief, Feinstein Institutes Research Finds
7.5.5 Feb 26, 2025: Esaote Group Presents Integrated Medical Imaging Solutions and Unveils Innovations in Ultrasound Technology
7.5.6 Feb 21, 2025: Rice-Led Study Finds Focused Ultrasound Therapy Improves Cancer Treatment
7.5.7 Jan 14, 2025: QT Imaging Introduces Machine Learning-Enabled Image Interpolation Algorithm to Substantially Reduce Scan Time
7.5.8 Dec 20, 2024: Building a Multilayered Drug Delivery System That’s Activated by Ultrasound
7.5.9 Sep 12, 2024: Patented Ultrasound Technologies Improve Diagnosis for Cancer and Other Diseases
7.5.10 Sep 06, 2024: Battling Chronic Pain with Noninvasive Focused Ultrasound
7.5.11 Sep 05, 2024: Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
7.5.12 Sep 05, 2024: New Cardiology Guidelines Require Use of Ultrasound Enhancing Agent during Stress Echo for Perfusion
7.5.13 Jul 30, 2024: Bilateral Focused Ultrasound Shown to be Safe, Effective for Patients with Lingering or Severe Essential Tremor
7.6 Strategy And Business Planning
7.6.1 Jun 17, 2025: Mindray North America Breaks Ground on Major Warehouse Expansion Project in Mahwah, NJ
7.6.2 May 12, 2025: Fujifilm Strengthens Partnership With the National Rural Health Association To Improve Access to Medical Imaging in Rural Communities
7.6.3 Apr 07, 2025: ContextVision Partners With University of Waterloo in Canada and InPhase Solutions AS in Norway
7.6.4 Mar 20, 2025: HCAP Partners Announces Launch of Integrated Diagnostic Services
7.6.5 Mar 18, 2025: NVIDIA Announces Collaboration With GE HealthCare
7.6.6 Mar 18, 2025: GE HealthCare Announces Collaboration With NVIDIA at GTC 2025
7.6.7 Mar 18, 2025: NVIDIA and GE HealthCare Collaborate to Advance the Development of Autonomous Diagnostic Imaging With Physical AI
7.6.8 Jul 23, 2024: Holston Medical Group Unveils New Outpatient Diagnostic Center in Duffield, Virginia
7.6.9 Jun 24, 2024: HeartFocus Joins Butterfly Garden to Develop Software Enabling Any Healthcare Professional to Conduct Lifesaving Echos on Butterfly’s Imaging Platform
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Ultrasound Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Ultrasound Systems Market, United States, Volume (Units), 2018-2033
Table 3: Ultrasound Systems Market, United States, Average Price ($), 2018-2033
Table 4: Ultrasound Systems Market, United States, Company Share by Revenue ($m), 2024
Table 5: Ultrasound Systems Market Pipeline Products
Table 6: GE HealthCare Technologies Raises USD1 Billion in Public Offering of 4.800% Senior Notes Due 2029
Table 7: Exo Imaging Raises USD14.2 Million in Debt Financing
Table 8: OPKO Health to Raise USD250 Million in Public Offering of 7.5% Notes Due 2044
Table 9: QT Imaging to Raise USD1 Million in PIPE Investment
Table 10: GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares
Table 11: GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares
Table 12: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country
List of Figures
Figure 1: Ultrasound Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Ultrasound Systems Market, United States, Volume (Units), 2018-2033
Figure 3: Ultrasound Systems Market, United States, Company Share (%), 2024